Literature DB >> 21180535

Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer?

Julian A Abrams1.   

Abstract

Entities:  

Year:  2009        PMID: 21180535      PMCID: PMC3002515          DOI: 10.1177/1756283X08102044

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  31 in total

1.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

2.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

3.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.

Authors:  Bergein F Overholt; Charles J Lightdale; Kenneth K Wang; Marcia I Canto; Steven Burdick; Roger C Haggitt; Mary P Bronner; Shari L Taylor; Michael G A Grace; Michelle Depot
Journal:  Gastrointest Endosc       Date:  2005-10       Impact factor: 9.427

4.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Authors:  E Montgomery; M P Bronner; J R Goldblum; J K Greenson; M M Haber; J Hart; L W Lamps; G Y Lauwers; A J Lazenby; D N Lewin; M E Robert; A Y Toledano; Y Shyr; K Washington
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

5.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Authors:  Douglas A Corley; Theodore R Levin; Laurel A Habel; Noel S Weiss; Patricia A Buffler
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

6.  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.

Authors:  Hashem B El-Serag; Thomas V Aguirre; Stephanie Davis; Mark Kuebeler; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

7.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.

Authors:  Douglas K Rex; Oscar W Cummings; Michael Shaw; Mark D Cumings; Roy K H Wong; Raj S Vasudeva; Donal Dunne; Emad Y Rahmani; Debra J Helper
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK.

Authors:  A Mandal; R J Playford; A C Wicks
Journal:  Aliment Pharmacol Ther       Date:  2003-05-15       Impact factor: 8.171

Review 9.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Karla Kerlikowske; Rajiv Verma; Patricia Buffler
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.

Authors:  Janusz Jankowski; Paul Moayyedi
Journal:  J Natl Cancer Inst       Date:  2004-06-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.